T1	chemical 0 10	Tezosentan
T2	chemical 17 47	endothelin receptor antagonist
T3	disease_or_phenotypic_feature 128 152	cardiovascular disorders
T4	disease_or_phenotypic_feature 170 183	heart failure
T5	disease_or_phenotypic_feature 194 218	congestive heart failure
T6	chemical 253 256	PDX
T7	chemical 295 299	drug
T8	disease_or_phenotypic_feature 312 325	breast cancer
T9	disease_or_phenotypic_feature 330 336	cancer
T10	chemical 366 372	oxygen
T11	chemical 444 447	TRH
T12	chemical 461 476	thyroid hormone
T13	disease_or_phenotypic_feature 495 514	metabolic disorders
T14	disease_or_phenotypic_feature 519 526	obesity
T15	disease_or_phenotypic_feature 533 542	pituitary
T16	chemical 600 604	GnRH
T17	chemical 605 613	agonists
T18	chemical 628 632	drug
T19	chemical 648 655	glucose
T20	disease_or_phenotypic_feature 766 778	brain cancer
T21	chemical 783 790	monitor
T22	chemical 835 843	estrogen
T23	chemical 844 855	metabolites
T24	disease_or_phenotypic_feature 868 881	breast cancer
T25	disease_or_phenotypic_feature 913 936	cerebellar degeneration
T26	chemical 938 946	hormonal
T27	disease_or_phenotypic_feature 971 975	deaf
T28	disease_or_phenotypic_feature 976 982	mutism
T29	disease_or_phenotypic_feature 987 1004	mental deficiency
T30	chemical 1006 1015	Raspberry
T31	chemical 1058 1069	antioxidant
T32	disease_or_phenotypic_feature 1081 1088	obesity
T33	disease_or_phenotypic_feature 1097 1114	Alzheimer disease
T34	chemical 1135 1145	anesthesia
T35	disease_or_phenotypic_feature 1167 1175	cataract
T36	chemical 1214 1217	DCs
T37	chemical 1248 1255	antigen
T38	chemical 1308 1311	DCs
T39	disease_or_phenotypic_feature 1357 1363	cancer
T40	disease_or_phenotypic_feature 1440 1445	small
T41	chemical 1491 1497	oxygen
T42	chemical 1574 1580	oxygen
T43	chemical 1620 1626	leptin
T44	disease_or_phenotypic_feature 1638 1645	obesity
T45	chemical 1652 1656	food
T46	disease_or_phenotypic_feature 1665 1678	hyperglycemia
T47	disease_or_phenotypic_feature 1684 1700	hyperinsulinemia
T48	chemical 1716 1730	growth hormone
T49	disease_or_phenotypic_feature 1734 1743	pituitary
T50	chemical 1760 1765	Ether
T51	chemical 1766 1776	anesthesia
T52	disease_or_phenotypic_feature 1807 1815	cataract
T53	chemical 1845 1849	drug
T54	chemical 1887 1891	drug
T55	disease_or_phenotypic_feature 1979 1985	cancer
T56	disease_or_phenotypic_feature 2044 2052	melanoma
T57	chemical 2131 2138	antigen
T58	chemical 2147 2153	MART-1
T59	chemical 2165 2180	hyaluronic acid
T60	chemical 2230 2234	drug
T61	disease_or_phenotypic_feature 2248 2254	cancer
T62	disease_or_phenotypic_feature 2299 2305	cancer
T63	chemical 2341 2347	oxygen
T64	chemical 2351 2359	nutrient
T65	chemical 2408 2416	thiamine
T66	chemical 2427 2434	enzymes
T67	disease_or_phenotypic_feature 2438 2445	obesity
T68	disease_or_phenotypic_feature 2450 2457	obesity
R1	treats Arg1:T2 Arg2:T3	
R2	treats Arg1:T1 Arg2:T3	
T69	corrected_disease_or_phenotypic_feature 164 183	acute heart failure
R3	treats Arg1:T2 Arg2:T69	
R4	treats Arg1:T1 Arg2:T69	
R5	treats Arg1:T1 Arg2:T5	
R6	treats Arg1:T2 Arg2:T5	
T70	missed_disease_or_phenotypic_feature 185 188	AHF
R7	treats Arg1:T1 Arg2:T70	
R8	treats Arg1:T2 Arg2:T70	
T71	missed_disease_or_phenotypic_feature 406 426	tumor aggressiveness
T72	missed_disease_or_phenotypic_feature 406 411;431 441	tumor metastasis
T73	corrected_chemical 600 613	GnRH agonists
T74	corrected_disease_or_phenotypic_feature 533 549	pituitary tumour
R9	causes_or_contributes_to Arg1:T73 Arg2:T74	
T75	corrected_chemical 1006 1022	Raspberry ketone
T76	corrected_disease_or_phenotypic_feature 1081 1114	obesity induced Alzheimer disease
R10	treats Arg1:T75 Arg2:T76	
T77	corrected_disease_or_phenotypic_feature 1440 1452	small tumors
R11	treats Arg1:T41 Arg2:T77	
T78	missed_disease_or_phenotypic_feature 2215 2220	tumor
T79	corrected_chemical 2155 2210	Iodinated hyaluronic acid oligomer-based nanoassemblies
R12	treats Arg1:T79 Arg2:T78	
R13	treats Arg1:T60 Arg2:T78	
T80	corrected_chemical 835 855	estrogen metabolites
R14	causes_or_contributes_to Arg1:T80 Arg2:T24	
T81	missed_disease_or_phenotypic_feature 1033 1053	cholinergic activity
T82	missed_disease_or_phenotypic_feature 1058 1077	antioxidant defense
R15	causes_or_contributes_to Arg1:T75 Arg2:T81	
R16	causes_or_contributes_to Arg1:T75 Arg2:T82	
T83	corrected_chemical 2113 2153	tumour-associated antigen melan-A/MART-1
T84	corrected_disease_or_phenotypic_feature 2036 2070	Primary melanoma tumour regression
R17	causes_or_contributes_to Arg1:T83 Arg2:T84	
T85	corrected_disease_or_phenotypic_feature 2036 2059	Primary melanoma tumour
R18	treats Arg1:T83 Arg2:T85	
